DA32 Life Science Tech Acquisition Corp
DALS
DALS was delisted on the 28th of July, 2023.
35 hedge funds and large institutions have $163M invested in DA32 Life Science Tech Acquisition Corp in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
80.22% more ownership
Funds ownership: 0% → 80.22% (+80%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.6M |
| 2 |
Deerfield Management
New York
|
+$15.8M |
| 3 |
BlackRock
New York
|
+$14.8M |
| 4 |
RA Capital Management
Boston,
Massachusetts
|
+$14.8M |
| 5 |
Driehaus Capital Management
Chicago,
Illinois
|
+$9.9M |
Top Sellers
DALS Hedge Fund Activity: Q3 2021 in Review
35 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp (DALS) for Q3 2021, worth a combined $163M.
Buyers outnumbered sellers: 35 funds opened new DALS positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $30.6M.
- 35 institutional investors held DA32 Life Science Tech Acquisition Corp (DALS) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $163M of DA32 Life Science Tech Acquisition Corp stock for Q3 2021.
- 35 funds opened new DA32 Life Science Tech Acquisition Corp positions in Q3 2021 and 0 closed out, a net change of +35 holders.
- The largest DA32 Life Science Tech Acquisition Corp buyer in Q3 2021 was Wellington Management Group, an estimated $30.6M added.
Based on aggregated 13F filings for Q3 2021.